Mumbai: Strand Life Sciences, a bioinformatics and integrated and specialized diagnostics company, has raised Rs60-80 crore from private equity firm Quadria Capital, a senior executive of the firm said. Strand Life Sciences is a business combination of Strand and Triesta Sciences, which was earlier part of Healthcare Global Enterprises Ltd, an oncology hospital chain. “With the merger with Triesta Sciences, we are able to now provide almost 3,500 tests. Quadria expects Strand Life Sciences to grow into Asia’s leading integrated and specialised diagnostics company, and become a leading provider of bioinformatics and research services worldwide, he said. “The demand for specialized diagnostics has been rising rapidly across the region.

Source: Mint February 07, 2018 18:22 UTC